生物医药企业与医院“面对面”

Group 1 - The core event is a clinical trial matchmaking meeting held at Suzhou University Affiliated First Hospital, facilitating direct discussions between 11 local biopharmaceutical companies and medical experts [1] - Suzhou has over 4,200 biopharmaceutical companies, most of which are in the growth stage, with 133 clinical trial projects conducted locally last year, representing a 51.14% year-on-year increase [1] - The local medical institutions, represented by Suzhou University Affiliated First Hospital, have significantly improved their clinical trial capabilities, which is expected to accelerate the implementation of more clinical trial projects in local healthcare facilities [1] Group 2 - Suzhou has developed a number of well-known innovative drug and device R&D companies in areas such as antibody drugs, cell and gene therapy, and in vitro diagnostics, including 26 national-level platforms [2] - Clinical trials are identified as an essential core step in transforming biopharmaceutical discoveries into practical methods for disease prevention, diagnosis, and treatment [2] - The Suzhou Industrial and Information Technology Bureau is encouraging local enterprises to conduct clinical trials and is exploring the establishment of special funding projects to support these initiatives [2]